Sparrow Pharmaceuticals Inc.
- Address
- 920 Southwest 6th Avenue
Sponsor Overview
Specializations
Cushing's syndrome and ACTH-dependent hypercortisolism
Sparrow Pharmaceuticals Inc. focuses on clinical research in Cushing's syndrome, including ACTH-dependent forms such as Cushing's disease, ectopic ACTH secretion, and ectopic corticotrophin-releasing hormone–driven disease. The sponsor's work in this area centers on disorders of excess cortisol production and related endocrine dysregulation.
- Endocrinology
- Hypercortisolism
- Adrenal and pituitary disorders
Its trial portfolio also includes patients with hypercortisolism linked to benign adrenal tumours and autonomous cortisol secretion.
Polymyalgia rheumatica
The sponsor is also active in polymyalgia rheumatica, with studies examining treatment use alongside prednisolone in adults living with this inflammatory rheumatic condition. This reflects interest in conditions requiring careful management of glucocorticoid therapy and symptom control.
- Rheumatology
- Inflammatory disorders
- Glucocorticoid-treated disease
Research activity in this area includes both PMR and related clinical presentations described under the same disease spectrum.
Adrenal steroid regulation
Across its studies, Sparrow Pharmaceuticals Inc. shows a clear therapeutic interest in steroidogenesis and the regulation of cortisol metabolism. The sponsor's research spans disorders where abnormal adrenal hormone production contributes to systemic complications and long-term disease burden.
- Adrenal endocrinology
- Cortisol excess
- Steroid metabolism
These programs connect endocrine and inflammatory indications through a shared focus on hormone balance and glucocorticoid-related clinical management.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Clofutriben (SPI-62) in the Management of ACTH-Dependent Cushing's Syndrome: A Clinical Trial |  Bulgaria Romania | Not Recruiting |
| Evaluation of Prednisolone and SPI-62 in the Management of Polymyalgia Rheumatica: A Randomized Controlled Trial |  Germany | Not Recruiting |
| Evaluation of Prednisolone with Clofutriben (SPI-62) or Placebo in Polymyalgia Rheumatica Patients: A Dose Adjustment Study | Germany Poland | Not Recruiting |
| Evaluation of SPI-62 for the Management of Hypercortisolism Associated with Benign Adrenal Tumors | Romania | Not Recruiting |
Data & Insights
This sponsor works with 3 molecules, of which 2 are not being studied by other sponsors.
This sponsor has worked with 19 sites across their trial portfolio.
Therapeutic Focus
- 1.Hormonal diseases2 trials89 other sponsors
- 2.Musculoskeletal Diseases2 trials238 other sponsors
Partnered Research Centres
19 centres- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
- Address
- Block 1 Staircase C Apartment 2 Room 2, Strada Crisului Nr 1, 500283 Brasov
- Address
- Chariteplatz 1, 10117 Berlin
- Address
- Triaditsa, Ulitsa Sveti Georgi Sofiyski 1, 1431 Sofia
- Address
- Ul Gen Augusta Emila Fieldorfa 2, 54-049 Wroclaw
- Address
- Wilmersdorfer Strasse 79, Charlottenburg, 10629 Berlin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Sparrow Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.